JO
SVA

John Overdeck’s Sinovac Biotech, Ltd SVA Stock Holding History

John Overdeck’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-18,302
Closed -$158K – 3902
2018
Q1 		$158K Sell
18,302
-34,171
-65% -$282K ﹤0.01% 3012
2017
Q4 		$413K Sell
52,473
-1,665
-3% -$12.5K ﹤0.01% 2560
2017
Q3 		$381K Sell
54,138
-8,114
-13% -$55.4K ﹤0.01% 2291
2017
Q2 		$420K Sell
62,252
-129,286
-67% -$708K ﹤0.01% 2455
2017
Q1 		$1.1M Buy
191,538
+75,416
+65% +$437K ﹤0.01% 1863
2016
Q4 		$685K Buy
116,122
+24,821
+27% +$149K ﹤0.01% 2287
2016
Q3 		$539K Buy
91,301
+34,307
+60% +$202K ﹤0.01% 2392
2016
Q2 		$338K Sell
56,994
-267
-0.5% -$1.64K ﹤0.01% 2487
2016
Q1 		$366K Sell
57,261
-16,367
-22% -$98.3K ﹤0.01% 2268
2015
Q4 		$421K Buy
73,628
+48,728
+196% +$262K ﹤0.01% 2070
2015
Q3 		$126K Sell
24,900
-16,806
-40% -$89K ﹤0.01% 2053
2015
Q2 		$219K Sell
41,706
-88
-0.2% -$465 ﹤0.01% 2586
2015
Q1 		$207K Sell
41,794
-43,094
-51% -$212K ﹤0.01% 2477
2014
Q4 		$444K Sell
84,888
-18,809
-18% -$95.9K ﹤0.01% 1780
2014
Q3 		$499K Buy
103,697
+4,799
+5% +$25.8K ﹤0.01% 1294
2014
Q2 		$558K Sell
98,898
-59,715
-38% -$363K ﹤0.01% 1561
2014
Q1 		$1.14M Buy
+158,613
New +$1.05M 0.01% 1165

Other funds holding SVA

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NAH
Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SSP
Sapphire Star Partners Redmond, Washington $74.7M AUM 5.87% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $163M AUM 68.53% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $359M AUM 23.01% 1-Year Est. Return
SIM
Spark Investment Management New York $51.2M AUM 87.14% 1-Year Est. Return

John Overdeck's SVA Position: Q2 2018 in Review

John Overdeck sold out of Sinovac Biotech, Ltd (SVA) in Q2 2018, closing a stake of 18,302 shares — an estimated $158K sold.

John Overdeck first reported a position in SVA in Q1 2014 and held it in 17 quarters. The position peaked at $1.14M in Q1 2014. 29 funds tracked by Wall St. Rank hold SVA as of Q2 2018.

  • John Overdeck reported no remaining Sinovac Biotech, Ltd position as of Q2 2018 after selling out during the quarter.
  • John Overdeck sold 18,302 Sinovac Biotech, Ltd shares in Q2 2018, an estimated $158K.
  • John Overdeck first reported a position in Sinovac Biotech, Ltd in Q1 2014 and held it in 17 quarters.
  • John Overdeck's Sinovac Biotech, Ltd position peaked at $1.14M in Q1 2014.
  • 29 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q2 2018.

Based on Two Sigma Investments's 13F filing for Q2 2018, filed 14 Aug 2018.